Here’s Why Cannabis Stocks Are on Fire Today

Cannabis stocks like Canopy Growth are rallying on the improving macro environment as well as improving company fundamentals.

| More on:
edit Cannabis leaves of a plant on a dark background

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Cannabis stocks were on fire yesterday. For example, Canopy Growth (TSX:WEED)(NYSE:CGC) was up 15%. Other cannabis stocks soared almost 20%. Today, they’re continuing their upward climb. So, why are these stocks roaring back to life?

Democrats gain control of the U.S. senate, driving cannabis stocks higher

The Democrats have regained control of the U.S. senate. This means that the democratic agenda can make it through. The cannabis industry has greater hope. We may see big opportunities in 2021.

Biden will be the next president. This changes the federal legislative environment for cannabis. It has been given a breath of fresh air. Because Biden doesn’t believe that anyone should be in jail for marijuana use, he wants to decriminalize marijuana use. According to Gallup polls, 66% of polled Americans favour national legalization of marijuana.

We can therefore expect more progress. The country will further destigmatize and normalize the use of cannabis. This backdrop is clearly hugely positive for cannabis stocks.

Cannabis stocks to buy today

So, this is definitely good news for the cannabis industry. But how can investors participate in this? Which cannabis stocks should we buy?

These are certainly difficult questions. The cannabis industry is still experiencing growing pains, and the best cannabis stocks have been rising. So, their valuations are rising. Canopy Growth is arguably the biggest and most established cannabis company today. Momentum is building. It’s being led by a few things. First is record revenue in the Canadian recreational business. Also, there is improved execution. Canopy is seeing an accelerating path to profitability.

Canopy is launching new products such as new cannabis beverages and gummies. This will open up new areas of growth. Further to this, Canopy has been razor-focused on the bottom line. The company has achieved significant cost savings. In turn, this will translate to positive EBITDA sometime this year. Finally, investors will have a real business to analyze.

Huge growth expected in the cannabis industry

It’s true that the cannabis bubble has burst. But this doesn’t mean that the potential growth in the cannabis industry has disappeared. The way that things have played out for cannabis stocks is actually quite typical.

First, investors get wind of a great product that will change the landscape. Cannabis is this type of product. It will change the medical field. It will also change the recreational substance industry. Next, investors bid up stock prices in their excitement. They bid them up to bubble levels, as this excitement turns into euphoria. Then the bubble inevitably bursts. This happens with the realization that it will take time and patience for their vision to be accomplished. Finally, we return to reasonably valued stocks that reflect a more realistic outlook. This is where we are today with cannabis stocks. They’re factoring in some of the inevitable struggles, but they’re also reflecting that they are on the cusp of great things.

Some estimates call for the legal cannabis market size to reach over $70 billion by 2027. A compound annual growth rate of 18% will take us there. The growth is huge.

Motley Fool: The bottom line

Cannabis stocks have been on a bumpy ride in the last few years. As investors, we always must keep our eyes on the long term. In the long term, the cannabis industry is attractive. It’ll take its place as an important part of our medical and social fabric. Canopy Growth stock is the go-to stock for us to gain exposure.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Karen Thomas has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »